 |
|---|
  |
Connectyx Launches MedFlash with Fred Meyer Stores - Division of KrogerConnectyx Technologies currently has two top tier Medical product divisions that are revolutionary in each business category MedFlash and MRN Manager. Both MedFlash(tm) and MRN Manager(tm) have broad appeal in their respective markets and are in the most sought after technology growth sectors: Personal health records and Revenue cycle management. MedFlash is a Personal Health Record device and has no equal in the marketplace. It should become ubiquitous by virtue of its simplicity and potential life saving features. MedFlash began as a simple 128MG flash drive with embedded software that enabled the owner to control their personal health information. The company has now developed a web based portal that will enable its owners not only to keep medical history but gives them the ability to download MRI’s, XRays, and a host of other medical and life style information all on a 1 GB flash drive that can plug into any computer and or be accessed directly from the Internet. MedFlash has experienced significant sales increases in the last 6 months due to a number of new customers. MedFlash has the price point that appeals to all age sectors and its distribution is not limited to the retail marketplace. MedFlash is being introduced to charitable organizations for fundraising efforts, has corporate logo appeal, can be sold via physicians practices, through insurance companies, given away as a corporate benefit, valuable to the travel industry for clients leaving the US, has the ability to be translated into many languages and the list goes on. Our second medical product – MRN - launched its initial robust claims management software, which specializes in reprocessing claims. Last year alone MRN successfully handled over 10 Million claims. The product has been tested through licensing agreements and now has proof positive that the product works in a variety of settings: medical offices, large multi physician practices, hospitals, clinics, medical mail order, and large medical billing companies. Throughout 2007 and into early 2008 the company made significant modifications which will enhance the product. Management is reviewing their business model to offer its service on a transactional basis which could bring significant revenue to the company. It should have a significant benefit for clients, typically saving them thousands of dollars during its periods of use. Why Invest in Connectyx Technologies?With the aging of the population and changes in medical technology and utilization, national health expenditures are expected to double, growing an average rate of 7.2 percent per year. As a result, the healthcare share of Gross Domestic Product (GDP) is expected to reach $4.1 trillion (or $12,782 per resident) by 2016. There are more than 6 billion healthcare claims processed per year. There are approximately 15,000 active Home Medical Equipment Market providers, 700,000 Physicians, and 120,000 Home Health Agencies and Hospitals. Approximately 75% of these groups will need a form of MRN. Healthcare experts agree that accelerating the claim to cash process remains at the top of the Healthcare industry’s agenda. MRN Manager provides the solution:
Why We Need MedFlash
Current MedFlash Resellers
Connectyx Exit Strategy CTYX will position itself to merge or be acquired at some point by an ISP or healthcare software provider. |
|---|
SmallCapVoice.com is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities members should buy or sell for themselves. Members should always check with their licensed financial advisor and their tax advisor to determine the suitability of any investment. This Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover this publication accepts compensation from some of the companies which it features. For compensation and complete disclaimer click here.